Global Health Impacts of Vector-Borne Diseases: Workshop Summary (2016)
Chapter: Appendix B: Agenda
Appendix B
Agenda
|
DAY ONE: TUESDAY, SEPTEMBER 16, 2014 |
|
| 8:45–9:15: | Registration and continental breakfast |
|
9:15–9:30: |
Welcoming remarks and overview: David A. Relman, James M. Hughes, Lonnie King |
|
SESSION I OVERVIEW OF VECTOR–HOST–ENVIRONMENTAL RELATIONSHIPS |
|
|
Moderator: Mary Wilson |
|
| 9:30–10:15: | Emerging vector-borne diseases in the United States: What is next, and are we prepared? |
|
Lyle Petersen, Centers for Disease Control and Prevention |
|
|
10:15–11:00: |
The past, present, and future of vector-borne plant diseases |
|
Rodrigo Almeida, University of California, Berkeley |
|
|
11:00–11:45: |
Changing patterns of vector-borne diseases in animals domestically and globally |
|
William Karesh, EcoHealth Alliance |
|
|
11:45–12:30: |
DISCUSSION |
|
12:30–1:15: |
LUNCH |
|
SESSION II THE CHANGING LANDSCAPE FOR VECTOR-BORNE DISEASES |
|
|
Moderator: James M. Hughes |
|
| 1:15–1:45: | Arbovirus evolution, vector competence, and virulence models: Changing patterns of infection |
|
Rebecca Rico-Hesse, Baylor College of Medicine |
|
|
1:45–2:15: |
Vector-borne disease emergence and spread in the European Union |
|
Jan Semenza, European Centre for Disease Control and Prevention |
|
|
2:15–2:45: |
Arbovirus disease surveillance capacity in the United States |
|
James Hadler, Yale University |
|
|
2:45–3:15: |
BREAK |
|
3:15–3:45: |
Recent introductions and spread of dengue and chikungunya in the Caribbean and the Americas |
|
Hal Margolis, Centers for Disease Control and Prevention |
|
|
3:45–4:15: |
The changing epidemiology and geographic spread of leishmaniasis and Chagas disease |
|
James Maguire, Harvard Medical School |
|
|
4:15–4:45: |
Changing paradigms for tick-borne diseases in the Americas |
|
Christopher Paddock, Centers for Disease Control and Prevention |
|
|
4:45–5:15: |
Blood donation screening for vector-borne diseases |
|
Susan Stramer, American Red Cross |
|
|
5:15–6:00: |
DISCUSSION |
|
6:00: |
ADJOURNMENT |
|
DAY TWO: WEDNESDAY, SEPTEMBER 17, 2014 |
|
| 8:30–9:00: | Registration and continental breakfast |
|
9:00–9:15: |
Welcome and summary of day one: David Relman |
|
SESSION III KEY FACTORS AND DRIVERS—CLIMATE, TRAVEL, LAND USE, TRANSPORTATION, AND TRADE |
|
|
Moderator: Lonnie King |
|
| 9:15–9:45: | Recent weather extremes and impacts on agricultural production and vector-borne disease outbreak patterns |
|
Ken Linthicum, U.S. Department of Agriculture |
|
|
9:45–10:15: |
Globalization, land use, global warming, and the invasion of West Nile virus |
|
Marm Kilpatrick, University of California, Santa Cruz |
|
|
10:15–10:45: |
BREAK |
|
10:45–11:15: |
The impact of environmental factors on mosquito-parasite interactions |
|
Matt Thomas, Pennsylvania State University |
|
|
11:15–11:45: |
Dengue, chikungunya, and malaria surveillance and response in Latin America and the Caribbean: The role of the Pan American Health Organization |
|
Luis Gerardo Castellanos, Pan American Health Organization |
|
|
11:45–12:30: |
DISCUSSION |
|
12:30–1:15: |
LUNCH |
|
SESSION IV NOVEL APPROACHES AND INTERVENTION STRATEGIES FOR VECTOR-BORNE DISEASE CONTROL |
|
|
Moderator: Gerald Keusch |
|
| 1:15–1:45: | Why did Gorgas succeed? (And why have we failed?) |
|
Paul Reiter, Institute Pasteur |
|
|
1:45–2:15: |
Towards the diagnosis and prognosis of emerging vector-borne diseases |
|
Barry Beaty, Colorado State University |
|
|
2:15–2:45: |
Malaria eradication strategies at the Gates Foundation |
|
Alan Magill, The Bill & Melinda Gates Foundation |
|
|
2:45–3:00: |
BREAK |
|
3:00–3:30: |
Development and evaluation of transgenic insects for use in the control of insect-borne disease |
|
Luke Alphey, Pirbright Institute |
|
|
3:30–4:00: |
Exploiting the specificity of virus–vector interactions for new disease control strategies |
|
Anna Whitfield, Kansas State University |
|
|
4:00–4:30: |
Dengue, Japanese encephalitis, West Nile, chikungunya, and yellow fever: Challenges for the development and use of vaccines |
|
Thomas Monath, Harvard Medical School |
|
|
4:30–5:15: |
DISCUSSION |
|
5:15–5:30: |
CLOSING REMARKS AND ADJOURNMENT |
